PAVmed (PAVM) Invested Capital (2015 - 2025)

PAVmed has reported Invested Capital for 11 years, with the latest figure at $33.4 million in Q4 2025.

• For the quarter ending Q4 2025, Invested Capital rose 25.54% year-over-year to $33.4 million; the trailing twelve-month figure through Dec 2025 stood at $33.4 million (up 25.54% YoY), and the FY2025 full-year result was $33.4 million, up 25.54% from the prior year.
• Invested Capital for Q4 2025 stood at $33.4 million, down from $39.4 million in the prior quarter.
• The five-year high for Invested Capital was $79.4 million in Q4 2021, with the low at -$570000.0 in Q2 2023.
• Average Invested Capital over 5 years is $40.1 million, with a median of $37.3 million recorded in 2021.
• Year-over-year, Invested Capital soared 8424.75% in 2021 and sank 100.8% in 2023.
• Tracing PAVM's Invested Capital over 5 years: stood at $79.4 million in 2021, then tumbled by 43.86% to $44.6 million in 2022, then plunged by 54.73% to $20.2 million in 2023, then soared by 31.83% to $26.6 million in 2024, then gained by 25.54% to $33.4 million in 2025.
• The last three Invested Capital figures came in at $33.4 million (Q4 2025), $39.4 million (Q3 2025), and $35.0 million (Q2 2025), per Business Quant data.

Peer Comparison